Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 839.30
+22.75 (2.79%)
Apr 2, 2026, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 133.01 billion as of April 2, 2026. Its market cap has decreased by -5.78% in one year.
Market Cap
133.01B
Enterprise Value
155.41B
Revenue
79.18B
Ranking
n/a
PE Ratio
30.74
Stock Price
839.30
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 133.01B, an increase of 32,603.11%. That is a compound annual growth rate of 25.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 133.01B | -21.87% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 278.21B |
| Wockhardt | 206.61B |
| Piramal Pharma | 188.79B |
| Eris Lifesciences | 184.55B |
| NATCO Pharma | 184.04B |
| Alembic Pharmaceuticals | 128.98B |
| Alivus Life Sciences | 121.46B |
| Cohance Lifesciences | 117.54B |